Population dynamics of islet-infiltrating cells in autoimmune diabetes - PubMed (original) (raw)
Population dynamics of islet-infiltrating cells in autoimmune diabetes
Angela M Magnuson et al. Proc Natl Acad Sci U S A. 2015.
Abstract
Type-1 diabetes in the nonobese diabetic (NOD) mouse starts with an insulitis stage, wherein a mixed population of leukocytes invades the pancreas, followed by overt diabetes once enough insulin-producing β-cells are destroyed by invading immunocytes. Little is known of the dynamics of lymphocyte movement into the pancreas during disease progression. We used the Kaede transgenic mouse, whose photoconvertible fluorescent reporter permits noninvasive labeling and subsequent tracking of immunocytes, to investigate pancreatic infiltrate dynamics and the requirement for antigen specificity during progression of autoimmune diabetes in the unmanipulated NOD mouse. Our results indicate that the insulitic lesion is very open with constant cell influx and active turnover, predominantly of B and T lymphocytes, but also CD11b(+)c(+) myeloid cells. Both naïve- and memory-phenotype lymphocytes trafficked to the insulitis, but Foxp3(+) regulatory T cells circulated less than their conventional CD4(+) counterparts. Receptor specificity for pancreatic antigens seemed irrelevant for this homing, because similar kinetics were observed in polyclonal and antigen-specific transgenic contexts. This "open" configuration was also observed after reversal of overt diabetes by anti-CD3 treatment. These results portray insulitis as a dynamic lesion at all stages of disease, continuously fed by a mixed influx of immunocytes, and thus susceptible to evolve over time in response to immunologic or environmental influences.
Keywords: Treg; cell tracer; reporter.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Fig. 1.
Dynamic profile of the pancreatic infiltrate during disease progression. (A) Background level of total CD45+ cells in pancreas was measured using flow cytometry. (B–E) The immune cell infiltrate in pancreata from mice at the different indicated ages was enumerated and profiled by flow cytometry. B, Inset shows 4- to 8-wk data on expanded scale. (F) Lymphocyte proliferation during disease progression in NOD. BrdU was administered (1.2 mg BrdU in 200 mL, two injections 10 h apart) to female NOD mice from 4 to 14 wk of age. At 22 h after the first injection of BrdU, BrdU incorporation into CD4+, CD8+ T cells, and CD45R+ B cells was measured by flow cytometry for the pancreas, PLNs, and spleen.
Fig. 2.
Monitoring cell trafficking to the pancreas. (A) Sample flow cytometry data for CD45+ cells from nonphotoconverted CLNs and 0-h, 1-min, and 24-h time points. (B) The proportion of CD45+ cells comprised of recent immigrants was measured by flow cytometry data generated at 0, 1, 3, or 7 d after photoconversion of the CLNs in 12- to 14-wk-old mice. (C) Islets in explanted pancreata from 10- to 12-wk-old mice were imaged by confocal microscopy 36 h after photoconversion of the CLNs. Kaede-red+ recent immigrants (red), β-cells (blue), and islet periphery (dashed white line). Representative z-stack projection shown here. Six pancreata per group were imaged.
Fig. 3.
Monitoring lymphoid and myeloid cell trafficking to the pancreas. The proportion of lymphocyte (A and B) or myeloid (C and D) populations that was comprised of recent immigrants in pancreas and inguinal LNs (ILNs) was measured by flow cytometry data generated at 0, 24, 72, or 168 h after photoconversion of the CLNs. (E) Schematic depiction of mathematical modeling of lymphocyte migration into the pancreas. (F) Migration ratios for lymphocyte subsets trafficking to pancreas, PLNs, or spleen vs. control ILNs were calculated from 24-h flow cytometry data. (G and H) Effector memory phenotype (G; CD62L, CD44) and T-cell activation (H; CD69) were assessed in resident and recent immigrant CD4+ T cells in pancreas, ILNs, and spleen. Each bar represents an individual mouse.
Fig. 4.
Monitoring Tconv and Treg cell trafficking to the pancreas. (A) The proportion of Tconv and Treg populations that was comprised of photoconverted cells at the site of photoconversion (CLNs). (B and C) Recent immigrants in the pancreas and ILNs were measured by flow cytometry. Data were generated at 0, 24, 72, or 168 h after photoconversion of the CLNs. (D) Migration of Tconv and Treg cells to the pancreas vs. the control ILNs was calculated from same flow cytometry data. ***P < 0.001 (aggregate P value).
Fig. 5.
Does antigen specificity affect migration into the lesions? The stages of disease initiation (4–6 wk) and established insulitis (12–14 wk) were examined in both NOD.Kaede (NOD) and BDC2.5.NOD.Kaede (BDC2.5) mice. Migration of lymphocytes (CD4+ T cells, CD8+ T cells and B cells) into the pancreas was measured by flow cytometry 72 h after photoconversion of the CLNs. (A) Proportion of cell population comprised of recent immigrants. (B) Migration of lymphocytes to pancreas, vs. control ILNs was calculated. (C) Number of recent lymphocyte immigrants in pancreas. (D) Number of photoconverted vs. total cells. Four mice per group, two separate experiments.
Fig. 6.
Tracing lymphocyte traffic to the pancreas after therapeutic anti-CD3 treatment. NOD.Kaede mice were treated with anti-CD3 at the onset of diabetes. (A) Histology showing insulitis in an anti–CD3-treated mouse at day 30 after first treatment. Image courtesy of J. Nishio. (B and C) On day 30 after diabetes onset, (B) migration, and (C) migration ratio (vs. ILN) of lymphocytes (CD4+ T, CD8+ T, B cells, Tconv, and Treg cells) into the pancreas was measured by flow cytometry, 72 h after photoconversion of the CLNs. Total of 5–6 mice per group.
Similar articles
- Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
Qu P, Ji RC, Shimoda H, Miura M, Kato S. Qu P, et al. Anat Rec A Discov Mol Cell Evol Biol. 2004 Dec;281(2):1326-36. doi: 10.1002/ar.a.20071. Anat Rec A Discov Mol Cell Evol Biol. 2004. PMID: 15386276 - Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW, Barber L, Chen KE, Alters SE. Goldrath AW, et al. J Autoimmun. 1995 Apr;8(2):209-20. doi: 10.1006/jaut.1995.0016. J Autoimmun. 1995. PMID: 7612149 - Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igμ(null) mice after polyclonal B cell reconstitution.
Vong AM, Daneshjou N, Norori PY, Sheng H, Braciak TA, Sercarz EE, Gabaglia CR. Vong AM, et al. J Transl Med. 2011 Jul 2;9:101. doi: 10.1186/1479-5876-9-101. J Transl Med. 2011. PMID: 21722394 Free PMC article. - The NOD mouse as a model of type I diabetes.
Tochino Y. Tochino Y. Crit Rev Immunol. 1987;8(1):49-81. Crit Rev Immunol. 1987. PMID: 2961513 Review.
Cited by
- Impacts of circulating cytokine levels and gene polymorphism predisposition on type 1 diabetes mellitus.
Alghamdi AH, El-Sherbini SM, Shatla IM, Mady EA, El-Refaei MF. Alghamdi AH, et al. Ann Pediatr Endocrinol Metab. 2024 Aug;29(4):250-257. doi: 10.6065/apem.2346178.089. Epub 2024 Aug 31. Ann Pediatr Endocrinol Metab. 2024. PMID: 39231486 Free PMC article. - Inhibition of CD226 Co-Stimulation Suppresses Diabetes Development in the NOD Mouse by Augmenting Tregs and Diminishing Effector T Cell Function.
Brown ME, Thirawatananond P, Peters LD, Kern EJ, Vijay S, Sachs LK, Posgai AL, Brusko MA, Shapiro MR, Mathews CE, Bacher R, Brusko TM. Brown ME, et al. bioRxiv [Preprint]. 2024 Jul 19:2024.07.16.603756. doi: 10.1101/2024.07.16.603756. bioRxiv. 2024. PMID: 39071293 Free PMC article. Preprint. - The IFIH1-A946T risk variant promotes diabetes in a sex-dependent manner.
Stock AJ, Gonzalez Paredes P, de Almeida LP, Kosanke SD, Chetlur S, Budde H, Wakenight P, Zwingman TA, Rosen ABI, Allenspach EJ, Millen KJ, Buckner JH, Rawlings DJ, Gorman JA. Stock AJ, et al. Front Immunol. 2024 Feb 29;15:1349601. doi: 10.3389/fimmu.2024.1349601. eCollection 2024. Front Immunol. 2024. PMID: 38487540 Free PMC article. - Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development.
Bruggeman Y, Martens PJ, Sassi G, Viaene M, Wasserfall CH, Mathieu C, Gysemans C. Bruggeman Y, et al. Front Endocrinol (Lausanne). 2023 Nov 10;14:1275316. doi: 10.3389/fendo.2023.1275316. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027120 Free PMC article. - The beta cell-immune cell interface in type 1 diabetes (T1D).
James EA, Joglekar AV, Linnemann AK, Russ HA, Kent SC. James EA, et al. Mol Metab. 2023 Dec;78:101809. doi: 10.1016/j.molmet.2023.101809. Epub 2023 Sep 20. Mol Metab. 2023. PMID: 37734713 Free PMC article. Review.
References
- Wållberg M, Cooke A. Immune mechanisms in type 1 diabetes. Trends Immunol. 2013;34(12):583–591. - PubMed
- Jörns A, et al. Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia. 2014;57(3):512–521. - PubMed
- Anderson MS, Bluestone JA. The NOD mouse: A model of immune dysregulation. Annu Rev Immunol. 2005;23:447–485. - PubMed
- Lee Y, et al. Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure. Immunity. 2006;25(3):499–509. - PubMed
Publication types
MeSH terms
Grants and funding
- AI051530/AI/NIAID NIH HHS/United States
- K01DK093766/DK/NIDDK NIH HHS/United States
- P01 AI054904/AI/NIAID NIH HHS/United States
- R37 AI051530/AI/NIAID NIH HHS/United States
- R01 AI051530/AI/NIAID NIH HHS/United States
- K01 DK093766/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials